Planning The Global Supply Chain Journey For Cell And Gene Therapy Companies

The number of cell and gene therapies entering clinical trials is growing at an increased rate. Having a strong supply chain strategy while understanding the import and export logistics for cell and gene therapies is vital for overcoming the challenges faced in a highly regulated environment.

In this webinar, Marken will discuss the many logistical challenges of cell and gene therapy trials while reaching diverse patient populations.

Learn about:

• The different supply chain strategies for cell and gene therapies
• How to take your existing logistics to the next level of regulatory compliance
• The various challenges faced with importing biological samples
• How to navigate the logistical challenges of exporting a clinical drug product
• Optimizing geographical footprint by utilizing Direct-to-Patient (DTP) distribution best practices
• The importance of remaining ISO, GDP and GMP compliant